🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today is #WorldBeeDay. Did you know we need bees and other pollinators for our entire ecosystem to survive? Janssen recognizes bees have an increasing threat from humans so we are doing what we can to help protect them. Watch this video to see how you can help #SaveTheBees!

Throughout #BladderCancerAwarenessMonth and beyond, we remain committed to improving the quality of life for people diagnosed with #bladdercancer by applying precision medicine to target bladder cancer. For more on our vision to eliminate cancer: bit.ly/3uR5L8Q

People are complicated. Leading them isn't. A simple plan for leading well:

We've been advancing scientific innovation in #prostatecancer for more than a decade and we're focused on making a difference for patients in the future by bringing forward new treatment approaches. #ASCO22 #PCSM

How to build a cancer pipeline: Big Pharma oncology heads on driving science forward PharmaVoice bit.ly/3x6FDa5 #oncology #ASCO22

What an #ASCO22, great meeting, making connections & seeing the passion for science in person. Here’s towards eliminating #cancer 🧬🔬JNJInnovative Medicine Johnson & Johnson

Today at #ASCO22, we presented data from a tumor-agnostic study that spans a wide range of advanced or metastatic solid tumors characterized by specific gene alterations. Learn more about the potential of precision medicine in treating biomarker-driven cancers.

Great article by Sean O'Neill following #ASCO22 thetimes.co.uk/article/advanc…

The graveyard of health tech pilots: why some experiments flourish and others fizzle statnews.com/2022/06/07/hea… via STAT

Health Equity: A Central Tenet in Health Care Quality thcqconsulting.com/blog/f/health-… prospects via THCQConsulting An excellent article on the need to accelerate our efforts to address health equity.

From the Great Lakes to infinity, Happy Canada Day !!!!

The oncology market is surging despite a decline in routine screenings pharmavoice.com/news/the-oncol… via @PharmaVOICE

At the IASLC #WCLC22 conference, we are highlighting the importance of biomarker testing like next-generation sequencing (NGS) testing for non-small cell lung cancer as it can identify mutations that may influence patients’ treatment options and, ultimately, their outcomes.

We're pleased to announce the European Commission granted a Conditional Marketing Authorization for our latest #multiplemyeloma treatment. #MMSM

A great article highlighting the passion from two of our best clinician leaders who work hard every day to help children live happier and healthier lives. "I'm Working to Develop Better Treatments for Children With Devastating Diseases" jnj.com/innovation/im-…

We are pleased to share that Janssen has joined the Precision Cancer Consortium, a group dedicated to improving access to comprehensive genomic testing for patients with cancer. prn.to/3xXAbHS

nationalgeographic.com/magazine/artic…

What if you made a genetic discovery that shaped the future of #Medicine—sounds like science fiction, right? Think again. From groundbreaking research to life-changing breakthroughs, we’re leading where medicine is going. #JNJ innovativemedicine.jnj.com/our-innovation…

We're heading to HLTH from October 20-23 to share how we're harnessing innovative technologies to revolutionize healthcare. Swipe to explore what you can learn from our leaders: social.jnj.com/3UgeZbb

Connect with us at #HLTH to hear more about how we’re leveraging #AI and #MachineLearning to advance our drug discovery efforts to help bring lifechanging treatments to patients.